Award
National Institute of Allergy and Infectious Diseases PA-20-185
Curing chronic Toxoplasma infection with novel and potent protease inhibitors
Recipient
University of Michigan at Ann Arbor
Award Amount
$603,601.00
Ceiling
$603,601.00
Awarded
July 30, 2025
Identifier
PA-20-185
NIH grant awarded to University of Michigan for developing novel protease inhibitors to cure chronic Toxoplasma infection, funded by NIAID.
Description
The project aims to develop new drugs to cure chronic ocular Toxoplasma gondii infection, focusing on protease inhibitors. It involves computational modeling, lead compound optimization, and in vivo testing in mice. The funding is provided by NIAID, part of NIH, and the project is associated with the University of Michigan at Ann Arbor.